• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

transferrin targeting liposomes encapsulating both boron and iodine contrast agent by CED to F98 rat glioma for boron neutron capture therapy

Research Project

Project/Area Number 20791022
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeSingle-year Grants
Research Field Cerebral neurosurgery
Research InstitutionOsaka Medical College

Principal Investigator

IKEDA Naokado  Osaka Medical College, 医学部, 助教 (50434775)

Project Period (FY) 2008 – 2009
Project Status Completed (Fiscal Year 2009)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2009: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2008: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Keywords悪性神経膠腫 / 硼素中性子捕捉療法 / トランスフェリン結合リポソーム / BNCT / BSH / リポソーム / トランスフェリン / boron neutron capture therapy / sodium borocaptate / transferrin / liposome / computed tomography
Research Abstract

Abstract : Objective : To augment the therapeutic efficacy of boron neutron capture therapy, we used transferrin (TF)-conjugated polyethylene-glycol (PEG) (TF-PEG) liposome encapsulating a sodium borocaptate and Iomeprol, an iodine contrast agent, with intratumoral convection-enhanced delivery (CED) in a rat glioma tumor model. Methods : The in vitro boron-10 (10B) concentration of F98 rat glioma cells was determined by inductively coupled plasma atomic emission spectrometry (ICP-AES) after incubation with either TF-PEG or PEG lposomes. For in vivo biodistribution studies, 10B concentrations within blood, normal brain tissue, and intracerebrally transplanted F98 cells were measured with ICP-AES after CED of the compounds, and computed tomography (CT) scanning was performed at selected time intervals.
Results : 10B concentrations of F98 cultured glioma cells in vitro 6 h after exposure to PEG and TF-PEG liposome were 16.1 and 51.9 ng 10B/106 cells, respectively. 10B concentrations in F98 glioma tissue 24 h after CED were 22.5 and 82.2 μg/g, by PEG and TF-PEG liposome, respectively, with lower 10B concentrations in the blood and the normal brain. Iomeprol provided vivid and stable enhanced CT imaging of the transplanted tumor even 72 h after CED by TF-PEG liposome. Conversely, tissue enhancement had already washed out at 24 h after CED of the PEG liposomes.
Conclusion : The combination of TF-PEG liposome encapsulating BSH and Iomeprol and intratumoral CED enables not only a precise and potent targeting of boron delivery on the tumor tissue but also the ability to follow the trace of boron delivery administered intratumorally by real-time CT imaging.

Report

(3 results)
  • 2009 Annual Research Report   Final Research Report ( PDF )
  • 2008 Annual Research Report
  • Research Products

    (3 results)

All 2008

All Presentation (3 results)

  • [Presentation] Biodistribution and Imaging studies on F98 rat glioma by convection enhanced delivery of transferring targeting PEG liposomes encapsulating both BSH and iodine contrast agent2008

    • Author(s)
      Miyata S, Kawabata S, Nonoguchi N, Yokoyama K, Doi A, Kuroda Y, Ikeda N, et.al.
    • Organizer
      Internationnal Congress on Neutron Capture Therapy
    • Place of Presentation
      Florence, Italy
    • Year and Date
      2008-11-02
    • Related Report
      2008 Annual Research Report
  • [Presentation] BSH封入トランスフェリン-PEGリポソームを用いた脳腫瘍内CEDのBNCTにおける有用性2008

    • Author(s)
      宮田至朗、川端信司、宮武伸一、横山邦生、土居温、池田直廉, ほか
    • Organizer
      第67回日本脳神経外科学会
    • Place of Presentation
      盛岡市
    • Year and Date
      2008-10-01
    • Related Report
      2008 Annual Research Report
  • [Presentation] BSE封入トランスフェリンーPEGリボソームを用いたラット脳腫瘍内CEDの有用性2008

    • Author(s)
      宮田至朗、川端信司、宮武伸一、横山邦生、土居温、池田直廉, ほか
    • Organizer
      第5回日本中性子捕捉療法学会学術大会
    • Place of Presentation
      倉敷市
    • Year and Date
      2008-07-25
    • Related Report
      2008 Annual Research Report

URL: 

Published: 2008-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi